PharPoint Research

  • Increase font size
  • Default font size
  • Decrease font size

PharPoint Research Expands in Research Triangle Park NC Area

Chapel Hill, NC, July 22, 2011 - PharPoint Research, Inc., a leading drug development service provider offering biotechnology and pharmaceutical companies expertise in project management, clinical monitoring, data management and biostatistics services, announces that it is expanding and has relocated their Chapel Hill, NC operations to new office space on Miami Boulevard in Durham, NC in the heart of the Research Triangle Park. “We are very excited about relocating our Chapel Hill operations to the RTP area. “ said Art Holmes, President and CEO. Mr. Holmes continued, “This relocation affords PharPoint the ability to better serve the needs of our clients and allows us to continue to strategically expand our business model.”

The new office is approximately 13,000 square feet, which is more than double the size of the previous Chapel Hill office. PharPoint recently added clinical project management and monitoring to its already well-established data management and biostatistics service offerings.

About PharPoint Research

PharPoint Research, Inc. is a pharmaceutical development service provider specializing in clinical operations, data management and biostatistics. Many of our staff have working relationships that span over a decade and includes some of the most talented professionals in the industry. PharPoint understands the importance of responsiveness and timely deliverables with exceptional quality. We pride ourselves on years of experience, superb repeat client rate and the ability to consistently exceed our clients' expectations. Founded in 2006, PharPoint is currently has offices in Durham, NC and Wilmington, NC. For more information, visit www.pharpoint.com.

For business opportunities contact:

Megan O’Keefe
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

For all other inquiries contact:

Diane DePalma
This e-mail address is being protected from spambots. You need JavaScript enabled to view it